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&MBTUJOGSBHNFOUTESJWFEJTFBTFQSPHSFTTJPO
JOBNVSJOFNPEFMPGFNQIZTFNB
A. McGarry Houghton,1 Pablo A. Quintero,1 David L. Perkins,2 Dale K. Kobayashi,3 Diane G. Kelley,3
Luiz A. Marconcini,1 Robert P. Mecham,4 Robert M. Senior,3,4 and Steven D. Shapiro1
1Division of Pulmonary and Critical Care Medicine and 2Division of Nephrology, Brigham and Women’s Hospital, Harvard Medical School, Boston,
Massachusetts, USA. 3Department of Medicine and 4Department of Cell Biology, Washington University School of Medicine, St. Louis, Missouri, USA.

Mice lacking macrophage elastase (matrix metalloproteinase-12, or MMP-12) were previously shown to be protected from the development of cigarette smoke–induced emphysema and from the accumulation of lung macrophages normally induced by chronic exposure to cigarette smoke. To determine the basis for macrophage accumulation in experimental emphysema, we now show that bronchoalveolar lavage fluid from WT smoke-exposed
animals contained chemotactic activity for monocytes in vitro that was absent in lavage fluid from macrophage
elastase–deficient mice. Fractionation of the bronchoalveolar lavage fluid demonstrated the presence of elastin
fragments only in the fractions containing chemotactic activity. An mAb against elastin fragments eliminated
both the in vitro chemotactic activity and cigarette smoke–induced monocyte recruitment to the lung in vivo.
Porcine pancreatic elastase was used to recruit monocytes to the lung and to generate emphysema. Elastin fragment antagonism in this model abrogated both macrophage accumulation and airspace enlargement.
*OUSPEVDUJPO
Chronic obstructive pulmonary disease (COPD) currently affects
over 18 million Americans and is the fourth leading cause of death
in the US. The burden of this disease promises to increase throughout the globe as smoking rates continue to climb in most developing countries (1). Emphysema, a major component of COPD,
is characterized by an inflammatory cell infiltrate composed of
alveolar macrophages, neutrophils, and CD4+ and CD8+ lymphocytes, and by the presence of proteinases in excess of their inhibitors within the alveolar space, which leads to destruction and permanent enlargement of the peripheral airspaces of the lung (2–7).
Macrophages are the predominant inflammatory cell type found
in the lung both under normal conditions and in the setting of
emphysema (8); however, the mechanisms responsible for the
recruitment of peripheral blood monocytes to the lung in the setting of emphysema remain poorly understood.
We have previously shown that mice deficient in macrophage
elastase (matrix metalloproteinase-12, or MMP-12) are protected from cigarette smoke–induced emphysema (9). As expected,
MMP-12+/+ mice displayed an increase in alveolar macrophage
number in response to cigarette smoke when compared with
non–smoke-exposed controls, but surprisingly, MMP-12–/– mice
did not. This is not simply due to a requirement of MMP-12 for
monocytes to properly emigrate from the vasculature to the lung
because monocytes do not synthesize MMP-12; only differentiated and activated tissue macrophages produce this proteinase
(10). Consistent with this fact, monthly instillations of monocyte
chemoattractant protein-1 (MCP-1), concomitant with cigarette
smoke exposure, resulted in a significant increase in alveolar
macrophages in the MMP-12–/– mice (although they were still proNonstandard abbreviations used: BAL, bronchoalveolar lavage; BALF, BAL fluid;
CL, chord length; COPD, chronic obstructive pulmonary disease; EF, elastin fragment; i.t., intratracheal(ly); MCP, monocyte chemoattractant protein; MMP-12,
macrophage elastase (matrix metalloproteinase-12); NE, neutrophil elastase; PPE,
porcine pancreatic elastase.
Conflict of interest: The authors have declared that no conflict of interest exists.
Citation for this article: J. Clin. Invest. doi:10.1172/JCI25617.

tected from the development of emphysema). Thus, MMP-12–/–
monocytes are capable of emigrating to the lung if the appropriate stimulus is present.
In addition to C-C chemokine–producing cells, the lung possesses other potential monocyte chemotactic factors that reside within
the ECM. Fragments of collagen (11), fibronectin (12), laminin
(13), and elastin (14–16) have all been shown to be chemotactic
for monocytes in vitro, but data to support a role for these agents
in vivo are lacking. In the current study, we show that MMP-12 is
required to generate the monocyte chemotactic activity present in
a model of cigarette smoke–induced emphysema in the mouse and
that elastin fragments (EFs) are required for macrophage accumulation and airspace pathology in this setting.
3FTVMUT
Bronchoalveolar lavage fluid from MMP-12+/+ but not MMP-12–/– smokeexposed mice contains monocyte chemotactic activity. Bronchoalveolar
lavage fluid (BALF) from WT smoke-exposed mice elicited a 5-fold
increase in monocyte chemotaxis in vitro compared with BALF
from control mice. In contrast, there was no chemotactic activity
in BALF from MMP-12–/– smoke-exposed mice above that seen in
non–smoke-exposed controls (Figure 1A). Of note, MMP-12 itself
was not chemotactic for monocytes in our assay (not shown). Initially, we assayed for C-C chemokines, substances well known for
their monocyte chemotactic properties. Real-time PCR was performed on lung RNA from WT mice exposed to smoke for 1, 3,
and 6 months, using primers for IL-1β, MCP-1, MCP-2, MIP-1α,
MIP-1β, and RANTES (data not shown). There was no significant
increase in RNA expression for any of these chemokines.
Having excluded the common chemokines, we began to search for
a novel factor that is generated in MMP-12+/+ but not MMP-12–/– mice
in the setting of cigarette smoke exposure. BALF from MMP-12+/+
and MMP-12–/– smoke-exposed mice was subjected to gel filtration
chromatography. Chemotactic activity was identified only in the
BALF from MMP-12+/+ mice, in fractions corresponding to a molecular mass of approximately 45 kDa. Significant chemotactic activity
was not present in any fraction of MMP-12–/– BALF (Figure 1B).
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EFs are the chemotactic factor present in BALF. Fractions of the BALF
demonstrating chemotactic activity for monocytes in vitro were
subjected to Western blot analysis using a panel of antibodies
against putative chemokine components of the ECM, including
thrombospondin, laminin, collagen, fibronectin, and elastin. Only
antibodies directed against elastin were detected in chemotactic
fractions (Figure 1C).
Additional in vitro assays of monocyte chemotaxis were performed using lung homogenates from MMP-12+/+ and MMP-12–/–
smoke-exposed animals and non–smoke-exposed controls. Consistent with the results from the experiments using BALF as the
chemoattractant, only the lung homogenates from MMP-12+/+
mice were chemotactic for monocytes. The lung homogenate demonstrated significantly more potent (5-fold higher) chemotactic
activity than the corresponding BALF. To show that EFs are the
chemotactic factor present in MMP-12+/+ smoke-exposed BALF
and lung homogenate, we repeated the monocyte chemotaxis
assays with the addition of BA4 mAb (50 nM) to the lower compartments. BA4, an mAb that was derived from an immunization

with the α-elastin fraction of insoluble elastin, completely eliminated the activity present in BALF and lung homogenate (Figure
1D). However, BA4 had no effect on formyl-Met-Leu-Phe–induced
(fMLP-induced) chemotaxis (not shown).
EF inhibition decreases cigarette smoke–induced lung macrophage accumulation in vivo. To illustrate that EFs influence cigarette smoke–
induced lung macrophage accumulation in vivo, we used a 1-week
cigarette smoke exposure protocol. Acute cigarette smoke exposure
experiments are certainly too brief to produce airspace disease or
emphysema, but they have been demonstrated to reliably produce
an inflammatory cell infiltrate (17, 18). Using this protocol, we
found that the monocyte recruitment elicited by the chemotactic
factors generated by cigarette smoke exposure in vivo can be inhibited 66% by BA4 (P = 0.0005) (Figure 2).
EFs are chemotactic for monocytes in vivo. To further prove that EFs
are capable of recruiting peripheral blood monocytes to the lung
in vivo, we administered purified EFs (no residual elastase in the
digest) intratracheally (i.t.) to WT mice. Intratracheal instillation
of EFs resulted in a dose-dependent increase in lung macrophage

'JHVSF
&'BOUBHPOJTNEFDSFBTFTDJHBSFUUFTNPLFmJOEVDFEMVOHNBDSPQIBHF
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Intratracheal instillation of PBS, EFs, and PPE

EF antagonism reduces PPE-induced accumulation of
alveolar macrophages in vivo. We used the PPE model of
emphysema to study the role of EFs in the recruitment
of peripheral blood monocytes to the lung in the setting
Macrophages/
BAL macrophages
BAL PMNs
of experimental emphysema. Intratracheal PPE is well
(104)
mm alveolar wall
(104)
known to induce airspace enlargement, generate EFs,
PBS
1.74 ± 0.06
10.24 ± 1.02
0
and, as we have shown here, increase lung macrophage
18.48 ± 1.79A
1.75 ± 0.26A
PPE (1 U)
3.99 ± 0.35A
EF peptides (10 μg)
2.88 ± 0.13A
19.85 ± 0.75A
0
content. We administered BA4 i.t. to elastase-recipient
EF peptides (100 μg)
3.77 ± 0.22A
19.63 ± 2.95A
0.07 ± 0.06
mice over either 3 or 21 days, using antibodies against
VGVAPG (5 μg)
3.01 ± 0.13A
–
–
collagen and laminin and an IgG1 isotype antibody as
EF ∼45-kDa fragment (4 μg) 4.15 ± 0.29A
–
–
controls. Treatment with BA4 resulted in 62% and 91%
reduction in lung macrophage content adjusted for
*OGMBNNBUPSZDFMMDPVOUTXFSFUBCVMBUFEJO#"-BOEPONBDmTUBJOFETFDUJPOTBU
alveolar tissue density on mac-3–stained sections at the
IPVST"1WTDPOUSPM1./ QPMZNPSQIPOVDMFBSMFVLPDZUF
3-day and 21-day time points, respectively, when compared with IgG1 isotype control (P < 0.001) (Figure 3,
content both in the BALF and in the lung parenchyma by 72 hours D–G). Collagen and laminin antibodies had no effect on macro(Table 1). Specifically, EFs, at doses of 10 μg and 100 μg, increased phage accumulation in this setting.
EF antagonism abrogates PPE-induced emphysema. Pancreatic elastase
the number of lung macrophages by 65% and 117%, respectively, compared with PBS-treated controls (P < 0.01). Intratracheal causes a direct proteolytic injury to the lung that results in a small
administration of VGVAPG, a frequently repeated sequence in increase in airspace size before it is rapidly cleared. The majority of
tropoelastin that is well known for its chemotactic properties, the airspace enlargement present after 21 days (∼80%) is the result
produced a 73% increase in lung macrophage content at 72 hours of the chronic inflammatory process initiated by PPE (19). There(P < 0.01) (Table 1). Furthermore, i.t. administration of the approx- fore, modification of this inflammatory process could result in a
imately 45-kDa EFs produced a significant increase in lung macro- reduction in the amount of PPE-induced emphysema. To show the
phage content at 72 hours (Table 1). EFs did not recruit neutrophils to the alveolar space above the level seen in controls.
Porcine pancreatic elastase is capable of recruiting monocytes to the lung
in vivo. Despite widespread use over the past 30 years, the exact
nature of the inflammatory component present in the porcine
pancreatic elastase (PPE) model of emphysema has yet to be fully
characterized. To prove that PPE generates an inflammatory cell
infiltrate, we instilled PPE i.t. and quantified the number of macrophages and neutrophils present in the BALF 1, 3, 7, 14, and 21
days later (Figure 3). A single i.t. dose of PPE (1 U = 7.4 μg) produced a significant increase in BALF macrophages (Figure 3A) and
neutrophils (Figure 3B) that peaked at 7 and 3 days, respectively.
The increase in lung macrophages was also evident in the lung
parenchyma on mac-3–stained sections (Figure 3C). Because PPE
generates airspace disease, the chord length (CL) was determined
so that the cell counts could be corrected for tissue density.

'JHVSF
&GGFDUTPG11&BOE&'BOUBHPOJTNPOMVOHNBDSPQIBHFDPOUFOU
JOWJWP11& 6μH PS1#4DPOUSPMXBTBENJOJTUFSFEJOUP
UIFMVOHTPG85NJDF#"-XBTQFSGPSNFECFGPSFUIFMVOHTXFSF
JOGMBUFEBOEGJYFEXJUICVGGFSFEGPSNBMJOBUEBZT    BOE
 "BOE# #"-NBDSPQIBHF " BOE#"-OFVUSPQIJM # DPVOUT
XFSFUBCVMBUFEVTJOHBIFNPDZUPNFUFSBOE)&."mTUBJOFEDZUP
TQJOT $ -VOHNBDSPQIBHFDPVOUTBSFFYQSFTTFEBTNBDSPQIBHFT
QFSIJHIQPXFSFEGJFMEBEKVTUFEGPSUJTTVFEFOTJUZPONBDmTUBJOFE
TFDUJPOTONJDFQFSHSPVQ#BSTSFQSFTFOU4&.1WT
DPOUSPM % 5PEFUFSNJOFUIFFGGFDUPG&'BOUBHPOJTNPONPOPDZUF
SFDSVJUNFOU 11&SFDJQJFOUNJDFSFDFJWFEμH#" O μH
BOUJmDPMMBHFOUZQF* DPM BOUJCPEZ O μHBOUJmMBNJOJO MBN 
BOUJCPEZ O PSμH*H(JTPUZQFDPOUSPMBOUJCPEZ O PWFS
UIFDPVSTFPGUIFEBZFYQFSJNFOUBOEFJUIFS#"PS*H(JTPUZQF
DPOUSPMPWFSUIFDPVSTFPGEBZT5IFNBDSPQIBHFDPVOUTBSF
FYQSFTTFEBTBCPWF#BSTSFQSFTFOU4&. 1WTDPOUSPM
1WT11&*H( &m( 3FQSFTFOUBUJWFNBDmTUBJOFETFD
UJPOTBSFTIPXOGPS1#4 & 11&*H( ' BOE11&#" ( BUUIF
EBZUJNFQPJOU.BHOJGJDBUJPO ¤
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dependence of macrophage accumulation and airspace enlargement on the presence of EFs, we repeatedly administered BA4 or
isotype control antibody i.t. to PPE-recipient mice and measured
the airspace dimensions (CL) and alveolar tissue and airspace areas
after 21 days. An additional control group received PBS only at
each instillation. BA4 treatment resulted in complete protection
from the development of emphysema, with the CL being the same
as that in PPE-treated mice after 24 hours, or the part of the injury
that is the result of direct proteolysis (Figure 4).
%JTDVTTJPO
Accumulation of macrophages in the interstitium, septum, and
alveolar airspace of the lung is one of the characteristic features of
pulmonary emphysema. Over 20 years ago, 2 separate reports by
Hunninghake et al. and by members of our group (R.M. Senior and
R.P. Mecham) demonstrated that EFs possessed chemotactic properties for monocytes in vitro, but, notably, not for mature alveolar
macrophages or neutrophils (14–16). That work fueled speculation that EFs may play a role in the recruitment of monocytes
to the lung in emphysema, given that the lung represents a significant source of elastin. Although mature, cross-linked elastic
fibers are not chemotactic, cryptic sequences of the protein may be
released within the ECM upon proteolysis by elastolytic enzymes,
such as MMP-12 or neutrophil elastase (NE). Despite these wellcharacterized chemotactic properties for monocytes in vitro, a role
for EFs in vivo in general, and in the pathogenesis of emphysema
in particular, has remained purely speculative. Moreover, with the
discovery of the large C-C chemokine family, the role of matrix
fragments in mediating chemotaxis seemed minimal, at best.
We entertained a number of potential mechanisms that could
explain the discrepancy that we observed in lung macrophage content between WT and MMP-12–/– smoke-exposed mice. We have
previously shown that MMP-12–/– peripheral blood monocytes are
capable of emigrating to the lung when an appropriate stimulus is


provided (9). Bone marrow transplantation was
used to demonstrate that the half-lives of WT
and MMP-12–/– lung macrophages are equivalent
(both are 18 days) and that resident alveolar macrophages do not proliferate, confirming that the
accumulation of lung macrophages in our model
was due to recruitment of new blood monocytes
to the lung and not due to local clonal expansion
of resident lung macrophages (data not shown).
The finding that BALF from MMP-12+/+, but
not from MMP-12–/–, mice contained monocyte chemotactic
activity led us to search initially for known, and later for novel,
chemotactic factors that were generated only in the MMP-12+/+
mice. We were able to detect only fragments of elastin, a known
substrate for MMP-12 (20), in chemotactic fractions of bronchoalveolar lavage (BAL). Inhibition of monocyte chemotaxis using BA4
confirmed the dependence of this chemotactic activity on EFs. EF
inhibition is relevant in vivo as well, given that BA4 administration
concomitant with cigarette smoke exposure significantly reduced
the accumulation of lung macrophages.
To demonstrate that EF-driven macrophage accumulation can
inhibit the development of emphysema, we turned to the PPE
model of emphysema. The PPE model, used to reliably generate
experimental emphysema for decades, has been criticized in the
past for rapidly producing airspace disease via direct proteolytic

'JHVSF
%FQJDUJPOPGBOFMBTUJOGJCFS5IFTDIFNBUJDEFQJDUTBOFMBTUJOGJCFS
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destruction of the alveolar wall, and thus having little in common
with the chronic, low-grade inflammation observed in emphysema. However, recent data suggest that the amount of emphysema
generated by direct proteolytic tissue destruction by PPE is minimal, compared with the lesion that develops over the ensuing 3–4
weeks related to endogenous inflammation and destruction. Modification of this inflammatory cascade has been demonstrated to
significantly reduce the resultant airspace disease (19), suggesting
that PPE generates a chronic inflammatory condition that more
closely resembles that of human emphysema than was previously
thought. We used the PPE model of emphysema here to show that
EF inhibition over a 3-week time course significantly decreases the
accumulation of lung macrophages and eliminates the development of airspace pathology, with the amount of airspace disease
present in the BA4 group being similar to that present 24 hours
after the administration of PPE, or the part of the injury that is the
direct result of PPE-mediated proteolysis. EF antagonism reduced
PPE-induced lung macrophage accumulation by 65% and 90% at
3 and 21 days, respectively. Prolonged treatment with BA4, therefore, achieves a more complete reduction in macrophage number,
but there certainly exists an alternative mechanism that would
account for the remainder. We have not been unable to detect
significant increases in the C-C chemokines, so there is likely an
alternate, as-yet unrecognized chemotactic factor.
EFs exert their chemotactic influence on monocytes via interaction with the elastin-binding protein (EBP) (21). Whereas the
hexapeptide VGVAPG, a commonly repeated sequence in human
elastin, is the most well-recognized ligand for this receptor,
numerous other EFs are capable of binding to the EBP. In addition to VGVAPG, all elastin-derived peptides that follow the motif
GXXPG or XGXPG (where X is a hydrophobic amino acid) display
chemotaxis for monocytes in vitro (22, 23). This is noteworthy
because the murine tropoelastin sequence does not contain the
VGVAPG sequence; however, it does contain significant quantities
of both GXXPG and XGXPG. In fact, these commonly repeated
sequences represent 21% of the entire mouse tropoelastin sequence.
Also of note, epitope recognition studies have demonstrated that
BA4 also binds to all peptides that follow the GXXPG and XGXPG
motifs (24), thus explaining why it is an effective inhibitor of the
chemotactic EFs generated in the mouse. Although the monocyte
chemotactic properties of EFs reside within these hydrophobic
penta- and hexapeptide repeats, the EFs generated in vivo tend
to be much larger. In the current study, we identified EFs in the
BALF from WT smoke-exposed mice in gel filtration fractions of
approximately 45 kDa (the broad peak of activity ranged from 35
to 50 kDa). Prior studies have demonstrated a wide range in the
size of EFs that possess monocyte chemotactic activity, from 10 to
50 kDa, that seems to depend on the type of elastin digested and
the enzyme used to digest it (14–16).
Mature elastin is a complex polymer of tropoelastin monomers
that have been irreversibly cross-linked by the enzyme lysyl oxidase. As a result, the mature protein is highly insoluble, and fragments generated from the polymer by proteolysis (Figure 5) are
heterogeneous in size and composition (the broad band detected
here is likely the result of several distinct fragments between 35
and 50 kDa, not 1 unique EF). Most contain multiple chain fragments joined through 1 or more cross-links, making their characterization by conventional proteomic approaches difficult if not
impossible (25). Given the extensive prior work showing that the
chemotactic properties of EFs reside within the commonly repeat-

ed penta- and hexapeptides, and that BA4 effectively inhibits them
both in vitro and in vivo, it is likely that the larger peptides we identified contain the chemotactic sequences cross-linked with other
regions of the protein. Furthermore, additional analysis of substrate specificities for MMP-12, within elastin, may provide insight
into the unique structural features of EFs generated in vivo.
Based on our previous findings and our current study of
MMP-12–/– mice, we hypothesize that alveolar macrophages become
activated upon chronic exposure to cigarette smoke; that these
macrophages release MMP-12 that degrades ECM components
including elastin; and that the degradation of elastin results in
the generation of EFs chemotactic for monocytes. The early influx
of neutrophils and NE caused by cigarette smoke exposure (17,
18) also contributes to the generation of EFs and provides a possible explanation as to why NE–/– mice are partially protected from
both the accumulation of macrophages and the development of
airspace enlargement upon exposure to cigarette smoke (26). The
interplay between macrophages and neutrophils in this process is
unlikely to be limited to the generation of EFs. We have previously
shown that NE is capable of degrading the tissue inhibitors of
metalloproteinases (TIMPs), the major inhibitors of MMP-12. Furthermore, MMP-12 degrades α1-antitrypsin, whose major function is to inhibit NE. Thus it appears that these proteinases are
able to indirectly augment each other’s function by degrading one
another’s inhibitors. However, it is not surprising that the lack of
MMP-12 would prevent the generation of cigarette smoke–induced
EFs in our model, given that the recruitment of neutrophils (and
NE) by cigarette smoke in mice is modest, when compared with
macrophage accumulation. Therefore, given the sparse representation of neutrophils in the cigarette smoke–induced emphysema in our mice that are housed in a sterile barrier facility, the
greater relative importance of the macrophage and its degradative enzymes is not surprising. Whereas PPE administration elicits
both macrophage and neutrophil inflammation (Figure 3), the
neutrophils are cleared rapidly in this setting, apparently leaving
the majority of alveolar tissue destruction to macrophages, which
maintain their upregulation, presumably via continued production of EFs. It is also possible that EFs induce MMP biosynthesis
(27). This EF chemotactic signal ultimately leads to enhanced lung
tissue destruction by placing more macrophages, and thus more
MMP-12, within close proximity of the airspace. In the absence of
repair, peripheral airspace enlargement is the result (28).
Although the findings here are limited to a model of emphysema, the concept that degradation products of elastin can drive a
macrophage-predominant, chronic inflammatory disease process
is potentially applicable to all diseases that occur in elastin-rich
organs, including coronary artery disease, peripheral vascular disease, and aortic aneurysm (29). Additionally, EF antagonism represents a potential therapeutic strategy for COPD, a disease for
which, to date, there are no available disease-modifying agents.
.FUIPET
Materials. All reagents were obtained from Sigma-Aldrich unless otherwise
noted. BA4 is a mouse anti-bovine IgG1-subclass mAb that was derived
from an immunization with the α-elastin fraction of insoluble elastin. It
has subsequently been shown to recognize the VGVAPG hexapeptide found
in human elastin, among others (24).
Mice. MMP-12–deficient mice and WT littermates were used for the experiments involving cigarette smoke exposure. The MMP-12–/– mice were generated in our laboratory as previously described (10). Briefly, intron 1 and
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exon 2 were disrupted by the insertion of the phosphoglycerolkinase promoter and neomycin resistance genes (PGK-neo). The construct was electroporated into RW4 ES cells, and correctly targeted clones were microinjected
into C57BL/6J blastocysts. Mice homozygous for the MMP-12 mutation
were backcrossed 10 generations into the C57BL/6J background. Age- and
sex-matched WT littermates were used as controls. All other experiments
were carried out in C57BL/6J mice purchased from Jackson Laboratory. The
Harvard Standing Committee for Animal Research at Harvard University
School of Public Health approved all animal experiments.
Cigarette smoke exposure. MMP-12+/+ and MMP-12–/– mice (n = 10) were
exposed to cigarette smoke from 2 unfiltered cigarettes (University of Kentucky) 6 days a week for 1, 2, 3, or 6 months (depending on the experiment)
using a smoking apparatus as previously described (9). The animals tolerated
the treatment without evidence of toxicity (carboxyhemoglobin levels ∼10%).
We additionally used an acute cigarette smoke exposure protocol in which
the mice were subjected to the smoke from 4 cigarettes a day for 7 days.
BALF analysis. At the conclusion of a given experiment, mice were sacrificed before performance of BAL via a 22-gauge i.v. catheter inserted into
the trachea. The lungs were lavaged with 1 ml DMEM 3 times to obtain the
BALF. The BALF was then centrifuged at maximum speed for 3 minutes,
and the supernatant was retained for further analysis. BALF obtained in
this way was subjected to gel filtration using an HPLC machine (Waters
Corp.) with a HiLoad Superdex 200 column (Amersham Biosciences). Each
BAL sample was loaded in a volume of 1 ml into a bed volume of 320 ml.
Fractions were collected in 1-ml aliquots using a flow rate of 1 ml/min in a
buffer composed of 50 mM Tris (pH 7.5), 10 mM CaCl2, and 150 mM NaCl.
Using this technique, the BALF was separated into 56 fractions based on
molecular weight. Each of the fractions was assayed for chemotactic properties as described below. Representative fractions (nos. 11 and 37) of the
BALF (100× concentration) were then subjected to Western blot analysis
using enhanced chemiluminescence. Polyclonal anti-elastin (rabbit antimouse) antibody at a 1:1,000 dilution was used for Western blot analysis.
BA4 mAb (described above) at a 1:1,000 dilution was used to confirm these
results. In addition, the BALF was analyzed for cellular content. The BALF
was centrifuged at 1,900 g for 3 minutes, the rbcs were lysed, and the BAL
was resuspended in 1.0 ml normal saline. Macrophage, neutrophil, and
total cell counts were determined using a hemocytometer and cytospins
stained with HEMA 3 (Biochemical Sciences Inc.).
Mouse lung elastin was digested using human leukocyte elastase (both
Elastin Products Co.) and subjected to gel filtration in a protocol similar
to that described above. The fraction corresponding to a molecular weight
of approximately 45 kDa was administered i.t. (see below) to demonstrate
its monocyte chemotactic properties in vivo. Tris buffer control was not
significantly different from PBS control (not shown).
Monocyte chemotaxis. Assays of monocyte chemotaxis were performed on
human peripheral blood monocytes using either BALF or lung homogenate
from WT and MMP-12–/– smoke-exposed and non–smoke-exposed control
mice as the chemoattractants in separate experiments. Human peripheral
blood monocytes were obtained by phlebotomy and purified using an elutriation centrifugation protocol. Monocytes were placed in the top wells of
a microchemotaxis chamber at a concentration of 1.0 × 105 cells per well
in DMEM. Depending on the assay, the lower compartments contained
either (a) MMP-12+/+ versus MMP-12–/– unfractionated BALF from smokeexposed and non–smoke-exposed control mice normalized to total protein
content of 2 mg/ml; (b) MMP-12+/+ versus MMP-12–/– BALF fraction (nos.
1–56) from smoke-exposed and non–smoke-exposed controls normalized
to total protein content of 8 μg/ml; or (c) MMP-12+/+ versus MMP-12–/– lung
homogenate from smoke-exposed and non–smoke-exposed control mice.
The chemotaxis assays using unfractionated BALF and lung homogenates
were repeated with the addition of 50 nM BA4 to the lower compartment


at the initiation of the experiment. Results are from a representative experiment performed in triplicate.
Real-time PCR. WT mice (n = 6) were exposed to cigarette smoke as described
above for 1, 3, or 6 months. Age- and sex-matched WT mice were used as
non–smoke-exposed controls. The lungs were removed and frozen at –80°C.
The lungs were homogenized in 1 ml cold TRIzol prior to RNA isolation
according to the manufacturer’s instructions. After treatment with DNase I
(Ambion Inc.) to remove contaminating DNA, the samples were reversetranscribed using RT-PCR beads with Poly(dT) oligonucleotides according
to the manufacturer’s instructions (Amersham Biosciences). Real-time PCR
analysis was performed using the GeneAmp 5700 Sequence Detection System (Applied Biosystems). The comparative CT method was employed using
GAPDH as an endogenous reference housekeeping gene. Serial dilutions of
a control sample of cDNA were used as the standard curve for each reaction. SYBR Green buffer (Applied Biosystems) was used as the fluorophore.
All experiments were performed in triplicate. The primer sequences were as
follows: IL-1β, forward primer, 5′-CCTCTGGTGTGTGACGTTC-3′; reverse
primer, 5′-TCTCGGAGCCTGTAGTGCAGT-3′; MCP-1, forward primer, 5′TTCTGGGCCTGCTGTTCAC-3′; reverse primer, 5′-GAGCCAACACGTGGATGCT-3′; MCP-2, forward primer, 5′-TCTCCCCTAATCTTCTCCAGG3′; reverse primer, 5′-CAGGCACCATCTGCTTGTAAC-3′; MIP-1α, forward
primer, 5′-CTGCCTGCTGCTTCTCCTACA-3′; reverse primer, 5′-CAACGATGAATTGGCGTGG-3′; MIP-1β, forward primer, 5′-TCTCTCCTCTTGCTCGTGGC-3′; reverse primer, 5′-TGGTGCTGAGAACCCTGGA-3′;
RANTES, forward primer, 5′-GCAAGTGCTCCAATCTTGCA-3′; reverse
primer, 5′-CTTGGCGGTTCCTTCGAGT-3′. Results are expressed as the
fold change from non–smoke-exposed controls.
Intratracheal administration of EFs, PPE, and BA4. WT mice were anesthetized with an i.p. injection of 2.5% Avertin. After the mice were appropriately sedated, they were intubated via direct visualization of the larynx using
a 22-gauge i.v. catheter in which the needle point had been filed down to
a blunt end and was used as a stylet. One unit (7.4 μg) PPE; 10 μg or 100
μg purified digested bovine ligament elastin (i.e., EFs); 5 μg VGVAPG (all
from Elastin Products Co.); the approximately 45-kDa EF (generated as
described above); or PBS or Tris buffer control (n = 4–6 for each group) was
administered i.t. in a total volume of 40 μl.
To demonstrate the dependence of monocyte recruitment to the lung
on EFs in the PPE model of emphysema, we administered BA4 to inhibit
the chemotactic properties of EFs. On day 1, WT mice were anesthetized
with 2.5% Avertin and received a dose of 10 μg BA4 (n = 9), 10 μg IgG1
isotype control antibody (n = 8), 10 μg anti–collagen type I antibody (Calbiochem) (n = 4), or 10 μg anti–laminin-5 antibody (R&D Systems) (n = 4)
i.t. as described above. Two hours later, all of the animals received a single
i.t. dose of PPE (1.0 U). On days 2 and 3, the mice again received i.t. doses of
BA4 or isotype control. The animals were sacrificed after 72 hours.
To evaluate the effects of EF inhibition on the progression of airspace
disease, we coadministered BA4 or IgG1 isotype control antibody i.t. to
PPE-recipient mice. In this experiment, mice received a single dose of i.t.
PPE (1.0 U) at time 0 and then received BA4 or control antibody on days 1,
2, 3, 5, 7, 10, 13, 16, and 19. The animals were sacrificed on the 21st day.
In a separate experiment, mice received either i.t. BA4 or IgG1 isotype
control concurrent with an acute cigarette smoke exposure protocol
(described above).
Lung tissue preparation. At the conclusion of each experiment, the lungs
were inflated to allow for further analysis. The animals were sacrificed at
the appropriate time point, the RV was perfused with normal saline to
remove blood, and the lungs were inflated at 25 cm H2O with 10% buffered
formalin for 10 minutes via an i.t. catheter. The lungs were then removed
and fixed for 24 hours before embedding in paraffin. Serial mid-sagittal
sections were obtained for morphological and histological analysis.
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In addition, lung tissue homogenates were prepared from mice exposed
to smoke for 2 months, by homogenization of the lungs in 5 ml of 50 mM
Tris, 150 mM NaCl, and 10 mM CaCl2 buffer.
Morphometry. Mid-sagittal sections stained with a modified Gill’s stain were
used to calculate the CL as previously described (9). Ten randomly selected
×200 fields per slide were photographed using MetaMorph (Molecular
Devices). The images were analyzed using Scion Image (Scion Corp.). Airway
and vascular structures were eliminated from the analysis. The images were
manually thresholded. The CLs were determined in both a horizontal and a
vertical plane, allowing for the calculation of alveolar airspace areas.
Immunohistochemistry. Alveolar, interstitial, and septal macrophages
were quantified with mac-3 immunostaining (rat anti-mouse antibody
at 1:1,000 dilution; BD Biosciences — Pharmingen) on mid-sagittal sections using the avidin-biotin HRP technique in which 3,3′-diaminobenzidine was the chromogenic substrate. Results are represented as the
average count from 5 different high-powered fields per slide that have
been corrected for millimeters of alveolar wall using the morphometric
data (as described above).
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